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OBJECTIVE: Hepatitis C virus (HCV) is one of the most
common blood-borne infections in the US. Although it carries a
potentially high economic burden for managed care systems,
HCV-related medical costs have not been widely investigated
using administrative data. Our objective was to analyze retro-
spective insurance claims to document resource utilization and
costs associated with chronic HCV among managed care enroll-
ees. METHODS: A large US claims database was analyzed from
1/1/2002 through 12/31/2006. Inclusion criteria were: 1 diag-
nosis of chronic HCV (ICD-9 070.44, 070.54, 070.70, or
070.71); no evidence of hepatitis B; 12 months of continuous
plan enrollment post-diagnosis. Per patient use and costs of
HCV-speciﬁc medical services and prescriptions were assessed
over 12 months post-diagnosis. HCV-speciﬁc encounters were
identiﬁed as claims on which HCV was a coded diagnosis.
Encounters were stratiﬁed by setting of care (e.g. ofﬁce visits,
hospitalizations). HCV-speciﬁc pharmacy utilization included
prescriptions for combination peginterferon or interferon with
ribavirin, peginterferon and interferon monotherapies, and con-
sensus interferon. RESULTS: 20,662 patients met all inclusion
criteria. Mean age was 49 years and 61% were male. Total
HCV-speciﬁc treatment costs were $6864 per patient. Patients
had, on average, 14 HCV-speciﬁc encounters. Nearly 65% had
an HCV-related ofﬁce visit, with 3 visits on average. Over 48%
had an HCV-speciﬁc laboratory test, with 5 tests on average and
total costs of $281. More than 14% of patients had an HCV-
related hospitalization, with average costs of $2078 per patient
and 5 inpatient days. 19% of patients had an HCV-speciﬁc
prescription with prescription costs ($3433) accounting for
nearly half of the total costs. HCV-speciﬁc home visits, skilled
nursing stays, and ER visits were seen in <5% of patients. CON-
CLUSION: Chronic HCV is a costly condition. Pharmacy and
inpatient services are primary drivers of HCV-related expendi-
tures. Expanded efforts in HCV treatment may result in cost
savings for managed care systems.
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OBJECTIVE: Chronic hepatitis C (CHC) is a life threatening
disease with long term consequences although the early stage is
considered ‘asymptomatic’. This study is to explore if higher
resource utilization occurs for early-stage CHC patients (case)
than non-CHC (control) subjects. METHODS: A large longitudi-
nal database, Health Improvement Network (THIN), was retro-
spectively analyzed. THIN contains medical records of over 2.2
million anonymous subjects representing UK population. Cases
were deﬁned with conﬁrmed CHC diagnosis and no records
related to ﬁbrosis, cirrhosis, decompensated liver conditions, and
liver transplantation. Propensity matching techniques were
applied to identify controls who did not have CHC diagnosis but
matched cases on CHC propensity based on age, weight, height,
gender, smoking, and alcohol consumption. Resource utilization
patterns based on the retrieved medical records were compared
between two groups. Odds ratios (OR) and 95% conﬁdence
intervals (CI) were derived from logistic regression models con-
trolling for follow-up duration; 95%CI excluding 1 is considered
statistically signiﬁcant.RESULTS:The case group (N = 1576) and
the control group (N = 5234) matched on all demographic
factors. On average, case subjects were 45.0 (13.3) years old,
64.7%male, andwere followed 4.21 years after CHCdiagnosis in
the database. Compared to the control, case subjects had 69%
greater chance of having specialist referral/visits (OR: 1.69,
95%CI: 1.50–1.91), and 70% higher probability of hospitaliza-
tion and emergency/accident visits (OR: 1.70; 1.46–1.98). Case
subjects also had 90% more chance using additional tests/
procedures (OR: 1.90; 1.68–2.15) with key drivers from endos-
copy (OR: 3.56; 2.39–5.31), MRI (OR: 1.93; 1.23–3.03), and
ultrasound (OR: 1.73; 1.17–2.57). Among CHC subjects, age
50–60 (N = 265) and >60 groups (N = 180) recorded signiﬁcantly
more health care resource uses than age < 40 (N = 545) and 40–50
(N = 586) group.CONCLUSION:CHC subjects consumedmore
health care resources than matching non-CHC controls in UK
even at the early stage of this serious liver disease.
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OBJECTIVE: S. aureus skin infections are a common cause of
hospitalization. Though rarely lethal, these infections impose
great morbidity on health care systems. Head-to-head therapeu-
tics studies commonly use LOS as an outcome, but rarely account
for differences in baseline characteristics. This study aims to
identify baseline characteristics associated with LOS among
patients with S. aureus skin infections. METHODS: Data were
extracted from the 1996–2005 NHDS. Data included age,
gender, race, geographic region, admission location, days of care,
insurance status, discharge status, and location. Patients were
included if they had both an ICD-9 code for skin infection
(680–684) and S. aureus (041.11). Patients were excluded if they
were <18 yrs, left against medical advice, transferred to a skilled
nursing facility, died, transferred from another hospital or had a
LOS <1 day. Each characteristic was individually tested for sig-
niﬁcance with a Cox regression model. Signiﬁcant variables were
entered into a multivariable Cox regression model to identify
independent predictors of LOS. RESULTS: Overall, 7094
patients met inclusion criteria and 5354 remained after exclu-
sions. Patients had a median (25th-75th percentile) LOS of 5
(4–8) days, age of 52 (40–69) years, 56% were male and 53%
were White. The following characteristics were associated with
longer LOS: advanced age (p = <0.0001), earlier survey year
(p = <0.001), female gender (p = 0.0003), widower (p = 0.0001),
Northeast geographic region (p = <0.0001), African American/
Black (p = 0.04), and Medicare (p = <0.0001). In contrast, small
hospital size was associated with a decreased LOS. In the multi-
variable regression model, advanced age, Medicare, earlier
survey year, and Northeast geographic region were indepen-
dently associated with an increased LOS while small hospital size
was independently associated with an decreased LOS (all
p-values were <0.0001). CONCLUSION: Five baseline charac-
teristics were independent predictors of LOS. These factors
should be considered in comparative retrospective evaluations of
patients with S. aureus skin infections.
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